A new study published in the New England Journal of Medicine suggests that prison inmates in the US can prove to be a potent weapon in the fight against hepatitis C virus infection as more than 16 percent of prisoners are infected with the virus and can be readily reachable for testing and treatment.
Why focus on inmates? Most hepatitis C virus infection in the U.S. is due to past use of injection drugs. More than 10 million Americans cycle in and out of prisons and jails each year, including nearly one of every three Americans infected with the hepatitis C virus. Because more than 95 percent of prisoners are eventually released, most hepatitis C virus-related illness will occur in the community, the researchers write in their article.
Scott A. Allen, MD, at the University of California, Riverside's School of Medicine is one of the authors of the NEJM
Watch him summarize the key points of the article in this short video:
In the video Dr. Allen explains why we all ought to pay attention to the hepatitis C virus; what we can expect if nothing is done to address the epidemic; why the criminal justice system is the best place to cure the greatest number of people infected with the virus; how the treatment of prisoners would benefit society in the long run; and why the high cost of treating prisoners (currently, a single treatment course costs approximately $84,000 per person) is justified.
Says Dr. Allen: "It is estimated that more than a million Americans could die because of the hepatitis C virus by 2060; those who are spared will require critical and costly treatments, including liver transplants."